1 |
FENG B L, LI H D. Genetic polymorphism of matrix metalloproteinase-9 and susceptibility to myocardial infarction: a meta-analysis[J]. Dis Markers, 2022, 2022: 5507153.
|
2 |
LU Y, LI S X, LIU Y T, et al. Sex-specific risk factors associated with first acute myocardial infarction in young adults[J]. JAMA Netw Open, 2022, 5(5): e229953.
|
3 |
SMITH S C Jr, ALLEN J, BLAIR S N, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute [J]. Circulation, 2006, 113(19): 2363-2372.
|
4 |
LI J, QIN R, WANG W, et al. Relationship between SNP rs1764391 and susceptibility, risk factors, gene-environment interactions of acute myocardial infarction in Guangxi Han Chinese population[J]. Curr Pharm Biotechnol, 2020, 21(1): 79-88.
|
5 |
WANG H H, ZHANG S F, WANG N, et al. Genetic variants of VEGFR-1 gene promoter in acute myocardial infarction[J]. Hum Genomics, 2019, 13(1): 56.
|
6 |
ZHANG Y X, HE X H, LI J R, et al. Functional genetic variant in ATG5 gene promoter in acute myocardial infarction[J]. Cardiol Res Pract, 2020, 2020: 9898301.
|
7 |
GAI M T, ADI D, CHEN X C, et al. Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors[J]. Sci Rep, 2021, 11(1): 11450.
|
8 |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 《中国循环杂志》编辑委员会. 急性心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2001, 29(12): 710-725.
|
9 |
陈继舜, 刘晓唤, 钱 航, 等. Gensini评分和HsCRP在预测PCI术后支架内再狭窄的价值[J]. 西安交通大学学报(医学版), 2018, 39(3): 336-340.
|
10 |
钟森杰, 李 静, 王陵军, 等. 基于痰瘀相关理论探讨冠心病脂质浸润机制及痰瘀同治的研究进展[J]. 中国中药杂志, 2023, 48(6): 1431-1437.
|
11 |
YAN Y K, LI S X, LIU Y, et al. Associations between life-course lipid trajectories and subclinical atherosclerosis in midlife[J]. JAMA Netw Open, 2022, 5(10): e2234862.
|
12 |
KOSMAS C E, RODRIGUEZ POLANCO S, BOUSVAROU M D, et al. The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease[J]. Diagnostics, 2023, 13(5): 929.
|
13 |
ZHANG Y N, GUO Z Z, WU T W, et al. SULT2B1b inhibits reverse cholesterol transport and promotes cholesterol accumulation and inflammation in lymphocytes from AMI patients with low LDL-C levels[J]. Clin Sci, 2020, 134(2): 273-287.
|
14 |
姜宏磊, 曹春林, 梁晓棠. 急性心肌梗死患者血脂变化分析[J]. 中西医结合心脑血管病杂志, 2011, 9(1): 20-21.
|
15 |
赵 珺, 张天锋, 李海燕, 等. 不同剂量他汀类药物对急性心肌梗死早期治疗效果的影响分析[J]. 中西医结合心血管病电子杂志, 2020, 8(29): 44, 78.
|
16 |
黎村艳, 陆建国, 曹友德, 等. 脂蛋白相关磷脂酶A2检测在急性冠脉综合征中的应用[J]. 国际检验医学杂志, 2013, 34(24): 3316-3317, 3319.
|
17 |
SKEIK N, NOWARIAK M E, SMITH J E, et al. Lipid-lowering therapies in peripheral artery disease: a review[J]. Vasc Med, 2021, 26(1): 71-80.
|
18 |
RAY K K, TROQUAY R P T, VISSEREN F L J, et al. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial[J]. Lancet Diabetes Endocrinol, 2023, 11(2): 109-119.
|
19 |
XIE G Q, SUN Y H, MYINT P K, et al. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes[J]. Lipids Health Dis, 2017, 16(1): 155.
|
20 |
SABATINE M S. PCSK9 inhibitors: clinical evidence and implementation[J]. Nat Rev Cardiol, 2019, 16(3): 155-165.
|
21 |
QI Z Y, HU L, ZHANG J J, et al. PCSK9 (proprotein convertase subtilisin/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36[J]. Circulation, 2021, 143(1): 45-61.
|
22 |
IACOCCA M A, WANG J, SARKAR S, et al. Whole-gene duplication of PCSK9 as a novel genetic mechanism for severe familial hypercholesterolemia[J]. Can J Cardiol, 2018, 34(10): 1316-1324.
|
23 |
JOHNSON K E, SIEWERT K M, KLARIN D, et al. The relationship between circulating lipids and breast cancer risk: a Mendelian randomization study[J]. PLoS Med, 2020, 17(9): e1003302.
|
24 |
LI Y Y, WANG H, YANG X X, et al. PCSK9 gene E670G polymorphism and coronary artery disease: an updated meta-analysis of 5, 484 subjects[J]. Front Cardiovasc Med, 2020, 7: 582865.
|
25 |
FEDORYAK O, ARAMA C, DIARRA I, et al. Association of the rs562556 PCSK9 gene polymorphism with reduced mortality in severe malaria among Malian children[J]. J Can Des Mal Infect De La Microbiol Med, 2020, 2020: 9340480.
|
26 |
CHUAN J L, QIAN Z X, ZHANG Y, et al. The association of the PCSK9 rs562556 polymorphism with serum lipids level: a meta-analysis[J]. Lipids Health Dis, 2019, 18(1): 105.
|